National Asset Management, Inc. Repligen Corp Transaction History

National Asset Management, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 16, 2024	BUY	$170.78 - $208.42 $27,666 - $33,764	162 Added 12.58%	1,450 $266,000
Q4 2023 Mar 15, 2024	SELL	$114.17 - $185.35 $18,495 - $30,026	-162 Reduced 11.17%	1,288 $231,000
Q3 2023 Dec 01, 2023	SELL	$138.78 - $176.51 $18,457 - $23,475	-133 Reduced 8.4%	1,450 $230,000
Q2 2023 Jul 27, 2023	SELL	$138.42 - $180.31 $23,116 - $30,111	-167 Reduced 9.54%	1,583 $223,000
Q1 2023 May 17, 2023	SELL	$154.26 - $198.1 $138,988 - $178,488	-901 Reduced 33.99%	1,750 $294,000
Q4 2022 Feb 21, 2023	SELL	$162.42 - $220.56 $9,420 - $12,792	-58 Reduced 2.14%	2,651 $448,000
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $124,325 - $198,562	775 Added 40.07%	2,709 $508,000
Q2 2022 Aug 12, 2022	SELL	$140.68 - $188.02 $44,876 - $59,978	-319 Reduced 14.16%	1,934 $315,000
Q1 2022 May 02, 2022	BUY	$161.19 - $257.96 $62,541 - $100,088	388 Added 20.8%	2,253 $425,000
Q4 2021 Jan 28, 2022	BUY	$247.59 - $304.47 $63,630 - $78,248	257 Added 15.98%	1,865 $494,000
Q3 2021 Nov 16, 2021	BUY	$194.77 - $324.21 $313,190 - $521,329	1,608 New	1,608 $465,000
Q2 2021 Aug 10, 2021	SELL	$165.87 - $220.95 $976,642 - $1.3 Million	-5,888 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$180.37 - $226.26 $805,171 - $1.01 Million	4,464 Added 313.48%	5,888 $1.15 Million
Q4 2020 Feb 04, 2021	SELL	$148.08 - $206.57 $163,924 - $228,672	-1,107 Reduced 43.74%	1,424 $274,000
Q3 2020 Nov 09, 2020	BUY	$122.51 - $158.27 $310,072 - $400,581	2,531 New	2,531 $351,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.